| 0 (0%) | 10-15 12:16 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 103.55 | 1-year : | 120.95 |
| Resists | First : | 88.66 | Second : | 103.55 |
| Pivot price | 85.31 |
|||
| Supports | First : | 83.98 | Second : | 81.08 |
| MAs | MA(5) : | 85.41 |
MA(20) : | 85.28 |
| MA(100) : | 77 |
MA(250) : | 71.82 |
|
| MACD | MACD : | 0.6 |
Signal : | 0.6 |
| %K %D | K(14,3) : | 67 |
D(3) : | 53.5 |
| RSI | RSI(14): 60.4 |
|||
| 52-week | High : | 88.66 | Low : | 53.56 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ INCY ] has closed below upper band by 13.7%. Bollinger Bands are 8.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 86.28 - 86.69 | 86.69 - 87.07 |
| Low: | 82.48 - 82.96 | 82.96 - 83.4 |
| Close: | 85.16 - 85.96 | 85.96 - 86.68 |
Wed, 15 Oct 2025
Chart based exit strategy for INCY - Portfolio Return Summary & Safe Entry Momentum Tips - newser.com
Wed, 15 Oct 2025
Why INCY stock could rally in 2025 - Exit Point & AI Driven Stock Movement Reports - newser.com
Tue, 14 Oct 2025
Does Early Cancer Therapy Data Shift the Long-Term Outlook for Incyte (INCY)? - simplywall.st
Tue, 14 Oct 2025
Incyte's (INCY) EVP and General Counsel Sold 4,100 Shares for $352,000 - sharewise.com
Tue, 14 Oct 2025
Incyte's (INCY) EVP and General Counsel Sold 4,100 Shares for $352,000 - Mitrade
Tue, 14 Oct 2025
How ESMO Congress Spotlight on Early Cancer Drugs Could Influence Incyte’s (INCY) Investment Outlook - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 195 (M) |
| Shares Float | 163 (M) |
| Held by Insiders | 2 (%) |
| Held by Institutions | 103.4 (%) |
| Shares Short | 8,500 (K) |
| Shares Short P.Month | 7,510 (K) |
| EPS | 4.23 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 21.48 |
| Profit Margin | 18.9 % |
| Operating Margin | 25.6 % |
| Return on Assets (ttm) | 11.5 % |
| Return on Equity (ttm) | 24.2 % |
| Qtrly Rev. Growth | 16.5 % |
| Gross Profit (p.s.) | 12.49 |
| Sales Per Share | 23.45 |
| EBITDA (p.s.) | 5.42 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 1,000 (M) |
| Levered Free Cash Flow | 649 (M) |
| PE Ratio | 20.75 |
| PEG Ratio | 0 |
| Price to Book value | 4.08 |
| Price to Sales | 3.74 |
| Price to Cash Flow | 17.14 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|